ASND

Ascendis Pharma
ASND

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$10.40B
EV
$10.75B
Shares Outstanding
62.45M
Beta
0.37

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$231.60
P/E 2025E
-
P/Revenue 2025E
14.10x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Ascendis Pharma A/S

gainify
ASND

Ascendis Pharma A/S

ASND

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare ...

Sector

Healthcare

Industry

Biotechnology

CEO

Mikkelsen, Jan

Employees

1,017

IPO Date

2015-01-28

Headquarters

Tuborg Boulevard 12, Hellerup, Capital Region of Denmark, 2900, Denmark

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.